Concepedia

D. Frye

DF

14

Publications

2.4K

Citations

13

H-Index

1987

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Breast Cancer Care

D. Frye is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, oncology, and breast cancer.

Top concepts

Publications per year

1987–2023

14

Publications

14

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

Philip Greenberg, Gabriel N. Hortobágyi, Terry L. Smith et al. · Journal of Clinical Oncology · 1996 · 753 citations

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

Frankie A. Holmes, R S Walters, R. Theriault et al. · JNCI Journal of the National Cancer Institute · 1991 · 745 citations

, , +14

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

Gabriel N. Hortobágyi, D. Frye, Aman U. Buzdar et al. · Cancer · 1989 · 199 citations · Full text

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.

Zillur Rahman, D. Frye, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1997 · 155 citations

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study.

Gabriel N. Hortobágyi, Gerald P. Bodey, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1987 · 129 citations

, , +15

Rows per page

1–5 of 14